Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance

Ernst Introduces Drug Expense Forecasting System

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, March 25, 7:08 p.m. – Ernst & Young L.L.P., New York, is setting up the RxManager program, a service that will help health insurers, health plans and pharmacy benefit managers analyze prescription expenses.

The system compares actual expenses with expense figures generated by a private Ernst prescription expense model.

The model predicts how much a group of patients will spend on prescriptions, using data for factors such as frequency of use and intensity of use as well as price and quality.

Ernst says it will adjust the tailor to fit each organization that uses it.

David Axene, a partner in Ernst’s health actuarial practice, will manage the service. Before Axene joined Ernst, he was an actuary at Milliman & Robertson Inc., Seattle. He helped found Milliman’s care guidelines division.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.